Ellen Beausang

Ellen Beausang leads the Oncology, COVID-19 and other advanced diagnostic segments. This includes oncology marketing, franchise and commercial initiatives as well as driving overall strategy for COVID-19 and other advanced testing. Ellen brings an extensive track record of leading commercial, marketing and franchise organizations to strategically bring up best in class products, services and solutions. As an industry veteran with over 25 years of experience, Ellen has held executive roles at leading pharmaceutical and diagnostic companies including Pfizer Pharmaceuticals, Thermo Fisher Diagnostics and Quest Diagnostics. Ellen is passionate about building high performing teams and best in class portfolios through a strong vision that always is customer centric and focused.

Prior to joining BioReference, Ellen was the Executive Director for Oncology at Quest Diagnostics where she managed the go-to market strategy and product development.

Ellen holds a Master’s Degree from Seton Hall University and a dual B.S. in Sociology/Psychology.